Menu
GWAS Study

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Wang Y, McKay JD, Rafnar T et al.

24880342 PubMed ID
GWAS Study Type
75750 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WY
Wang Y
MJ
McKay JD
RT
Rafnar T
WZ
Wang Z
TM
Timofeeva MN
BP
Broderick P
ZX
Zong X
LM
Laplana M
WY
Wei Y
HY
Han Y
LA
Lloyd A
DM
Delahaye-Sourdeix M
CD
Chubb D
GV
Gaborieau V
WW
Wheeler W
CN
Chatterjee N
TG
Thorleifsson G
SP
Sulem P
LG
Liu G
KR
Kaaks R
HM
Henrion M
KB
Kinnersley B
VM
Vallée M
LF
LeCalvez-Kelm F
SV
Stevens VL
GS
Gapstur SM
CW
Chen WV
ZD
Zaridze D
SN
Szeszenia-Dabrowska N
LJ
Lissowska J
RP
Rudnai P
FE
Fabianova E
MD
Mates D
BV
Bencko V
FL
Foretova L
JV
Janout V
KH
Krokan HE
GM
Gabrielsen ME
SF
Skorpen F
VL
Vatten L
NI
Njølstad I
CC
Chen C
GG
Goodman G
BS
Benhamou S
VT
Vooder T
VK
Välk K
NM
Nelis M
MA
Metspalu A
LM
Lener M
LJ
Lubiński J
JM
Johansson M
VP
Vineis P
AA
Agudo A
CF
Clavel-Chapelon F
BH
Bueno-de-Mesquita HB
TD
Trichopoulos D
KK
Khaw KT
JM
Johansson M
WE
Weiderpass E
TA
Tjønneland A
RE
Riboli E
LM
Lathrop M
SG
Scelo G
AD
Albanes D
CN
Caporaso NE
YY
Ye Y
GJ
Gu J
WX
Wu X
SM
Spitz MR
DH
Dienemann H
RA
Rosenberger A
SL
Su L
MA
Matakidou A
ET
Eisen T
SK
Stefansson K
RA
Risch A
CS
Chanock SJ
CD
Christiani DC
HR
Hung RJ
BP
Brennan P
LM
Landi MT
HR
Houlston RS
AC
Amos CI
Chapter II

Abstract

Summary of the research findings

We conducted imputation to the 1000 Genomes Project of four genome-wide association studies of lung cancer in populations of European ancestry (11,348 cases and 15,861 controls) and genotyped an additional 10,246 cases and 38,295 controls for follow-up. We identified large-effect genome-wide associations for squamous lung cancer with the rare variants BRCA2 p.Lys3326X (rs11571833, odds ratio (OR) = 2.47, P = 4.74 × 10(-20)) and CHEK2 p.Ile157Thr (rs17879961, OR = 0.38, P = 1.27 × 10(-13)). We also showed an association between common variation at 3q28 (TP63, rs13314271, OR = 1.13, P = 7.22 × 10(-10)) and lung adenocarcinoma that had been previously reported only in Asians. These findings provide further evidence for inherited genetic susceptibility to lung cancer and its biological basis. Additionally, our analysis demonstrates that imputation can identify rare disease-causing variants with substantive effects on cancer risk from preexisting genome-wide association study data.

3,442 European ancestry adenocarcinoma cases, 3,275 European ancestry squamous cell carcinoma cases, 4,631 cases, up to 15,861 controls

Chapter III

Study Statistics

Key metrics and study information

75750
Total Participants
GWAS
Study Type
Yes
Replicated
3,589 European ancestry adenocarcinoma cases, 3,202 European ancestry squamous cell carcinoma cases, 3,455 cases, up to 38,295 controls
Replication Participants
European
Ancestry
Finland, U.S., Poland, Czech Republic, Italy, Russian Federation, Romania, U.K., Estonia, Hungary, Slovakia, France, Norway, Sweden, Iceland, Netherlands, Greece, Canada, Germany, Spain, Denmark
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.